Home › Funds › Sofinnova Investments, Inc. › JBIO

Sofinnova Investments, Inc. position in JBIO

JADE BIOSCIENCES INC · Health Care

Sofinnova Investments, Inc. reported holding 107,391 shares of JBIO (JADE BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$2.4M, representing 0.13% of its reported portfolio and ranking #44 among its reported holdings. Sofinnova Investments, Inc. has disclosed JBIO holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)107.39K sh
Reported value held$2.39M
Portfolio Weight0.13%
First reportedQ2 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s JBIO position evolved

Sofinnova Investments, Inc. first disclosed a stake in JBIO in Q2 2025 at 107,391 shares (US$1.1M). The position peaked in Q2 2026 at 107,391 shares, worth US$2.4M. Across 5 filings, Sofinnova Investments, Inc. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 107,391 shares valued at US$2.4M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 107.39K $1.07M New
Q3 2025 107.39K $926.78K Hold
Q4 2025 107.39K $1.66M Hold
Q1 2026 107.39K $1.51M Hold
Q2 2026 107.39K $2.39M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JBIO and 13F data

JBIO (JADE BIOSCIENCES INC) is a Health Care company. 106 other funds we track also report a position in JBIO — the largest reported positions include Fairmount Funds Management LLC (US$101.2M), RA CAPITAL MANAGEMENT, L.P. (US$81.6M), Venrock Adviser, LLC (US$71.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JBIO

All JBIO fund holders →

FAQ

How long has Sofinnova Investments, Inc. held JBIO?

Sofinnova Investments, Inc. has disclosed JBIO holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Sofinnova Investments, Inc.'s current position in JBIO?

As of Q2 2026, Sofinnova Investments, Inc. holds 107.39K shares of JBIO (JADE BIOSCIENCES INC), valued at $2.39M, representing 0.13% of its reported portfolio and ranking #44.

Has Sofinnova Investments, Inc. been buying or selling JBIO?

In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. held unchanged its position in JBIO. The position peaked in Q2 2026 at 107.39K shares.

Which other funds hold JBIO?

Other major institutional holders of JBIO include Fairmount Funds Management LLC, RA CAPITAL MANAGEMENT, L.P., Venrock Adviser, LLC, among 106 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.